Microbot Medical Inc.MBOTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P18
Within normal range
vs 3Y Ago
-9.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-49.28%
Q2 202510.47%
Q1 2025-69.96%
Q4 202438.71%
Q3 2024-40.98%
Q2 202419.13%
Q1 2024-32.89%
Q4 2023-10.03%
Q3 202310.73%
Q2 202342.12%
Q1 2023-30.04%
Q4 202216.65%
Q3 20225.41%
Q2 2022-3.89%
Q1 2022-4.16%
Q4 2021-32.67%
Q3 20215.27%
Q2 2021-15.20%
Q1 2021-19.40%
Q4 20201.42%
Q3 2020-183.33%
Q2 2020186.66%
Q1 2020-22.19%
Q4 2019-44.25%
Q3 2019-179.04%
Q2 201982.48%
Q1 2019-89.76%
Q4 2018-7.73%
Q3 20181.26%
Q2 2018-12.98%
Q1 20188.79%
Q4 20172.97%
Q3 20175.73%
Q2 2017-86.57%
Q1 2017-103.24%
Q4 20165729.86%
Q3 2016-694.34%
Q2 201681.91%
Q1 2016-7.87%
Q4 201596.26%